The cart's Podcast

ADC delivery

Antibody drug conjugate (ADC) is a calss of relatively invonational anticancer drugs. Through ADC delivery, the drug is released after the receptor delivers the entire structure into the cell, and then the chemotherapeutic drug acts in the cell.

antibody design

Creative Biolabs has adopted a variety of strategies in antibody design and engineering to generate new monoclonal antibodies with accommodating conjugation chemistry sites for the creation of ADCs. 

ADC Technologies

Creative Biolabs, a leading services provider who is committed to providing high-quality services to promote the development of antibody-drug conjugates (ADCs) and other innovative targeted protein therapeutic agents, recently upgraded their advanced ADC Technologies covering all crucial stages in ADC development. 

antibody-drug conjugates

Three major components define antibody-drug conjugates—the monoclonal antibody, a cytotoxic payload, and a molecular linker that covalently bridges the other two components. 

Immunized phage display scfv library

At Creative Biolabs, the scFv Phage Display is established originally with an immunized phage display scFv library against the interested antigen. 

CD20 CAR T

Early phase IIa trial in 11 patients with refractory or relapsed B-cell lymphoma confirmed the feasibility and efficacy of anti-CD20 CAR-T cell therapy.

Physiological CAR T

This physiological CAR T consists of an antigen receptor and a CD3ζ intracellular signaling domain with/without a TM and a spacer region, which can also be engineered into immune cells to target its ligands expressed on tumor cells.

Candy-Cart-USA-products

Creative Biolabs offers a wide selection range of CAR T products targeting many different tumor associated antigens respectively.

T-Cell-Receptor-Binding-Affects-the-Dynamics-of-the-PeptideMHC-I-Complex

As an innovative technique developer, Creative Biolabs now provides high affinity TCR targeting specific antigen for immunodeficiency.

psoriasis-erythrodermic-treatment

Blastoma is a general term for any tumor in a group of cancers that almost uniquely affects children. CAR T for blastoma therapy is based on such types.